SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1194NEW YORK, May 7 (Reuters) - Forest Laboratories Inc. (NYSE:FRX - News) said on Wnigel bates-5/7/2003
1193(OT - NVGN) John, You piqued my curiosity enough to take a look at the new arBiomaven-5/2/2003
1192o.t. - Yale Researchers Find Phenoxodiol Overwhelmingly Effective for Treating CJohn McCarthy-5/1/2003
1191Marc - Thanks for asking about it. btw - a poster on Yahoo informed me that jmJohn McCarthy-4/29/2003
1190FRX may be cool, but statistically there is a strong correlation in the biotech JMarcus-4/29/2003
1189Hi Marc I'm a scardy cat and until Frx releases a press release saying theJohn McCarthy-4/28/2003
1188John, why haven't you posted a celebratory message here? We closed at $8.15JMarcus-4/28/2003
11872003] - Retinoids as candidate targets for alzheimer’s disease treatment (TargetJohn McCarthy-4/24/2003
1186parking .. edit ... think this was done about mid 2002 Merz & Co (SPC/GB02John McCarthy-4/24/2003
1185<<< If the np data is in line, I expect frx to munch ntii probably soonJohn McCarthy-4/24/2003
1184I got it straight from PF. AD is 20 mg/day, NP is 40 mg/day. NP at 20mg isn'rkrw-4/23/2003
1183Thanks John. A much better and more comprehensive answer than I could possiblyBiomaven-4/23/2003
1182How do the doses compare? Note:great questions but I really don't have soliJohn McCarthy-4/23/2003
1181<i>AD and NP have different doses</i> How do the doses compare? It&Biomaven-4/23/2003
1180Wall Street Journal Story - (posted on Yahoo) THE WALL STREET JOURNAL European John McCarthy-4/23/2003
1179This was a subsequent post on Yahoo .... It clarified what was *actually* said. John McCarthy-4/23/2003
1178Your interpretation is correct.rkrw-4/23/2003
1177<i>Conference Call stated Neuro Pain results coming in next few weeks follBiomaven-4/23/2003
1176Notes from Yahoo on frx CC ... Currently doing Pre Release Marketing for AD ExpJohn McCarthy-4/22/2003
1175Snippet from FRX Press Release - Forest Laboratories Reports Record Fiscal FourJohn McCarthy-4/22/2003
1174Updated JMDutton Report 4/16/03 jmdutton.com John McCarthyJohn McCarthy-4/16/2003
1173Memantine Data Presented at the American Academy Of Neurology (AAN) Annual MeetiWilliam F. Wager, Jr.-4/7/2003
1172FWIW - Aricept versus Memantine+Aricept trial data for moderate to severe AD. [John McCarthy-4/6/2003
1171Hi John-- Thanks for your thoughts on the upcoming Redchip conference. Only reWilliam F. Wager, Jr.-4/6/2003
1170Been with this since Nov 1997. 6000 shares at $2.50! I think it will take anothPete Russo-4/5/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News